| http://www.w3.org/ns/prov#value | - The addition of this novel, oral compound offers patients the potential for advanced treatment options and an improved patient experience to address RA and other autoimmune diseases, said John Leonard, M.D., senior vice president, global research and development, Abbott.
|
